Education
About Us
Working with TipRanks
Follow Us
Humana Inc (HUM)
NYSE:HUM
HUM Stock Chart & Stats
$175.40
$0.14(0.05%)
At close: 4:00 PM EST
$175.40
$0.14(0.05%)
Day’s Range― - ―
52-Week Range$186.00 - $315.35
Previous CloseN/A
Volume197.44K
Average Volume (3M)1.89M
Market Cap
$21.10B
Enterprise Value$30.31B
Total Cash (Recent Filing)$22.12B
Total Debt (Recent Filing)$12.64B
Price to Earnings (P/E)17.8
Beta0.68
Next Earnings
Apr 29, 2026EPS Estimate
10.15Next Dividend Ex-DateN/A
Dividend Yield1.38%
Share Statistics
EPS (TTM)-3.96
Shares Outstanding120,273,070
10 Day Avg. Volume3,893,347
30 Day Avg. Volume1,891,683
Financial Highlights & Ratios
PEG Ratio-0.51
Price to Book (P/B)1.87
Price to Sales (P/S)0.26
P/FCF Ratio12.79
Enterprise Value/Market Cap1.44
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit0.24
Enterprise Value/Ebitda9.48
Forecast
1Y Price Target
$226.88Price Target Upside29.35% Upside
Rating ConsensusHold
Number of Analyst Covering19
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Member Retention And Medical Loss RatioImproved membership retention driven by better onboarding and benefit design supports lower medical loss ratios and strengthens long-term profitability.
Pricing And Product MixShifting away from loss-leader plans and focusing pricing on durable, higher-quality members should help sustain margins and maximize lifetime member value.
Stars Diversification And Medicare Advantage Share GainsEfforts to improve Stars diversification and capture share from competitors that reduced benefits position the company to expand Medicare Advantage membership and benefit from favorable market dynamics.
Bears Say
Adverse Selection From Richer BenefitsRelatively richer benefit offerings compared with peers raise the risk of attracting higher-using members, which could increase medical loss ratios and undermine margin recovery.
Claims Visibility And Churn UncertaintyLimited visibility into claims development and undisclosed churn and retention assumptions make it difficult to reconcile rapid membership growth with the company's margin targets, heightening valuation uncertainty.
Policy Risk And Advance Rate PressureA disappointing advance rate notice creates a policy overhang that increases pressure on profitability and leaves the company disproportionately exposed in Medicare Advantage.
Humana News
HUM FAQ
What was Humana Inc’s price range in the past 12 months?
Humana Inc lowest stock price was $186.00 and its highest was $315.35 in the past 12 months.
What is Humana Inc’s market cap?
Humana Inc’s market cap is $21.10B.
When is Humana Inc’s upcoming earnings report date?
Humana Inc’s upcoming earnings report date is Apr 29, 2026 which is in 74 days.
How were Humana Inc’s earnings last quarter?
Humana Inc released its earnings results on Feb 11, 2026. The company reported -$3.96 earnings per share for the quarter, beating the consensus estimate of -$4.002 by $0.042.
Is Humana Inc overvalued?
According to Wall Street analysts Humana Inc’s price is currently Undervalued.
Does Humana Inc pay dividends?
Humana Inc pays a Quarterly dividend of $0.885 which represents an annual dividend yield of 1.38%. See more information on Humana Inc dividends here
What is Humana Inc’s EPS estimate?
Humana Inc’s EPS estimate is 10.15.
How many shares outstanding does Humana Inc have?
Humana Inc has 120,273,070 shares outstanding.
What happened to Humana Inc’s price movement after its last earnings report?
Humana Inc reported an EPS of -$3.96 in its last earnings report, beating expectations of -$4.002. Following the earnings report the stock price went down -3.254%.
Which hedge fund is a major shareholder of Humana Inc?
Currently, no hedge funds are holding shares in HUM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$226.88 (29.35% Upside)
$226.88 (29.35% Upside)
Blogger Sentiment
Bullish
HUM Sentiment 66%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 5.9%
Last 30 Days ▲ 45.0%
Last 30 Days ▲ 45.0%
News Sentiment
Bearish
Bullish news 31%
Bearish news 69%
Bearish news 69%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.88%
12-Months-Change
Fundamentals
Return on Equity
6.98%
Trailing 12-Months
Asset Growth
5.61%
Trailing 12-Months
Company Description
Humana Inc
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
HUM Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balances meaningful operational and strategic progress (notably strong membership growth, improved retention, CenterWell tailwinds, EPS outperformance in 2025, and capital efficiency gains) with significant near-term headwinds. The dominant risks are a large ~$3.5 billion STARS headwind, 2026 MA margins slightly below breakeven, and uncertainty from the advance rate notice. Management emphasizes confidence in long-term targets (2028) and has plans to adapt to funding changes, but near-term performance will be constrained by STARS and rate uncertainty.View all HUM earnings summariesHUM Revenue Breakdown
95.20% Premiums
3.76% Services
1.04% Investment income
HUM Stock 12 Month Forecast
Average Price Target
$226.88
▲(29.35% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
36.73% Mutual Funds
7.54% Other Institutional Investors
28.40% Public Companies and Individual Investors